Skip to main content
. 2022 Sep 14;14(18):4458. doi: 10.3390/cancers14184458

Figure 2.

Figure 2

Immune checkpoint blockade therapy for suppression of cervical cancer. (i) Depicts immune evasion due to expression to immune checkpoint molecules. (ii) Shows action of immune checkpoint blocking molecule (such as pembrolizumab) that promotes T cell recognition and killing of tumor cells.